Combine Scientific Meeting of the Australia-New-Zealand-Gynaecology-Oncology-Group

Activity: Participating in or organising an event types › Contribution to conference

Description

Targeting BCL-2 in treatment refractory MYCN-driven high-grade serous ovarian cancer; utilizing high-grade serous ovarian cancer patient derived xenograft models.
PeriodApr 2016
Event typeConference

Keywords

  • BCL2
  • High grade serous ovarian cancer
  • Apoptosis
  • Cytotoxic